Business
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas Schuh as Chief Financial Officer (CFO), effective December 1, 2025. Andreas Schuh joins Opterion with over 20 years of leadership experience across biotech, pharma, and medical devices. He has held senior finance and operations roles at Nuclidium, Jeito, Roivant, Novartis, and Al
About this update from Novartis Ag
[{"type":"image","alt":"Opterion Health AG","displaySize":"","headline":null,"caption":"Opterion Health AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":106,"url":"https://media.zenfs.com/en/globenewswire.com/8d337ae1fab32870c9f53cc33075717e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2qavAkwxpNP.mOp2PCntrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8d337ae1fab32870c9f53cc33075717e","width":300,"height":106},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/2qavAkwxpNP.mOp2PCntrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8d337ae1fab32870c9f53cc33075717e","width":300,"height":106}},"lazy":false},{"type":"image","alt":"Andreas Schuh, Chief Financial Officer, Opterion Health AG","displaySize":"","headline":null,"caption":"Andreas Schuh, Chief Financial Officer, Opterion Health AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":715,"url":"https://media.zenfs.com/en/globenewswire.com/d6cb16cb930a0abd6801640471b7fcf8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XcGYNEUyQoDuh7OkrQb9uA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTExNDQ7Y2Y9d2VicA--/https://media.zenfs.com/en/globenewswire.com/d6cb16cb930a0abd6801640471b7fcf8","width":600,"height":715},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Eu9n_Lp8Aq70Fd29RBq3pA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTc2MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d6cb16cb930a0abd6801640471b7fcf8","width":600,"height":715}}},{"type":"text","content":"MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas Schuh as Chief Financial Officer (CFO), effective December 1, 2025.","length":287,"tagName":"p"},{"type":"text","content":"Andreas Schuh joins Opterion with over 20 years of leadership experience across biotech, pharma, and medical devices. He has held senior finance and operations roles at Nuclidium, Jeito, Roivant, Novartis, and Alcon, where he drove major fundraising rounds, managed multi-billion R&D budgets, and delivered significant margin improvements through strategic cost management and governance. Most recently, as CFO at Nuclidium, Andre...